From $250M to $750M by 2030: India Life Science Analytics Market Size Projections and Key Adoption Drivers

The India life science analytics market has transitioned from steady growth to a clear expansion phase, reflecting the country’s commitment to leveraging data for scientific and healthcare progress. Valued at $250 million in 2022, the market is projected to grow to $750 million by 2030, driven by adoption across multiple segments—including drug discovery, diagnostics, and public health. Understanding these "India life science analytics market size 2023-2030" projections is critical for businesses, investors, and researchers aiming to capitalize on this opportunity.

Drug discovery is the largest segment, contributing 40% of 2022 revenue. Pharma and biotech firms rely on analytics to screen drug candidates, predict side effects, and optimize formulations. For example, a Hyderabad-based company used analytics to identify a novel antibiotic target, reducing R&D costs by $2 million. Diagnostics follows at 30%, with tools that analyze protein and genetic markers enabling early disease detection. A 2023 study in Indian Journal of Medical Research found that microarray analytics tools improved cancer diagnosis accuracy by 22% compared to traditional methods, driving demand in hospitals.

Public health segments, though smaller (15% of 2022 revenue), are growing fastest. Analytics tools track disease outbreaks, assess vaccine efficacy, and optimize resource distribution—critical given India’s population density and challenges like malaria and tuberculosis (TB). The government’s National Health Mission (NHM) has integrated analytics into its TB elimination program, using data from 200,000+ clinics to identify high-risk regions and target interventions. This has reduced TB incidence by 8% in pilot areas, highlighting analytics’ public health impact.

To explore how these "India life science analytics market size 2023-2030" projections align with India’s scientific and healthcare goals, stakeholders must examine segment-specific drivers. Drug discovery will remain dominant, but public health and diagnostics are poised for exponential growth. The detailed report on this market size, including revenue forecasts and adoption trends, is available here: India life science analytics market size 2023-2030.